Development of an analytical methodology from toxicokinetic to clinical studies for the anti-migraine drug frovatriptan
- 1 January 2000
- journal article
- particular analytes
- Published by Springer Nature in Chromatographia
- Vol. 52 (1) , S113-S119
- https://doi.org/10.1007/bf02493141
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Bioanalytical methods validation: A critique of the proposed FDA guidanceChromatographia, 2000
- Cross validation in bioanalysis: Why, when and how?Chromatographia, 2000
- Comparison of the Cardiovascular Effects of the Novel 5-HT1B/1D Receptor Agonist, SB 209509 (VML251), and Sumatriptan in DogsJournal of Cardiovascular Pharmacology, 1997
- Application issues in bioanalytical method validation, sample analysis and data reportingJournal of Pharmaceutical and Biomedical Analysis, 1995
- Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic StudiesPharmaceutical Research, 1992